Brian Wiley Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Brian Wiley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Brian Wiley. Brian Wiley is Chief Commercial Officer in NEWLINK GENETICS CORP ($NLNK) and VP of Business Development in NEWLINK GENETICS CORP ($NLNK).
Latest Insider Trading Transactions of Brian Wiley
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 2018 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Option Exercise | A | 7.85 | 110,000 | 863,500 | 110,000 | |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Payment of Exercise | F | 10.06 | 603 | 6,066 | 18,150 | 18.8 K to 18.2 K (-3.22 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Payment of Exercise | F | 8.47 | 1,237 | 10,477 | 18,753 | 20 K to 18.8 K (-6.19 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Option Exercise | A | 10.55 | 75,000 | 791,250 | 75,000 | |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Payment of Exercise | F | 11.04 | 603 | 6,657 | 19,271 | 19.9 K to 19.3 K (-3.03 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Payment of Exercise | F | 10.28 | 1,237 | 12,716 | 19,874 | 21.1 K to 19.9 K (-5.86 %) |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Option Exercise | A | 10.78 | 30,000 | 323,400 | 30,000 | |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | A | 34.73 | 18,259 | 634,135 | 18,259 | |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 35.20 | 1,000 | 35,200 | 19,942 | 20.9 K to 19.9 K (-4.78 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 34.26 | 295 | 10,107 | 20,942 | 21.2 K to 20.9 K (-1.39 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Grant | A | 0.00 | 6,382 | 0 | 21,237 | 14.9 K to 21.2 K (+42.96 %) |
| Mar 04 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 20,000 | 235,800 | 99,000 | |
| Mar 04 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 46.24 | 1,250 | 57,800 | 14,855 | 16.1 K to 14.9 K (-7.76 %) |
| Mar 04 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 45.05 | 15,000 | 675,750 | 16,105 | 31.1 K to 16.1 K (-48.22 %) |
| Mar 04 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 44.03 | 3,750 | 165,113 | 31,105 | 34.9 K to 31.1 K (-10.76 %) |
| Mar 04 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 20,000 | 235,800 | 34,855 | 14.9 K to 34.9 K (+134.63 %) |
| Feb 19 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 10,000 | 117,900 | 119,000 | |
| Feb 19 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 40.07 | 10,000 | 400,700 | 14,855 | 24.9 K to 14.9 K (-40.23 %) |
| Feb 19 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 10,000 | 117,900 | 24,855 | 14.9 K to 24.9 K (+67.32 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 20,000 | 235,800 | 129,000 | |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | A | 43.65 | 23,400 | 1,021,410 | 23,400 | |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 40.98 | 10,000 | 409,800 | 13,686 | 23.7 K to 13.7 K (-42.22 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 39.68 | 10,000 | 396,800 | 23,686 | 33.7 K to 23.7 K (-29.69 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 20,000 | 235,800 | 33,686 | 13.7 K to 33.7 K (+146.13 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Grant | A | 0.00 | 7,400 | 0 | 13,686 | 6.3 K to 13.7 K (+117.72 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Payment of Exercise | F | 43.65 | 540 | 23,571 | 6,286 | 6.8 K to 6.3 K (-7.91 %) |
| Feb 05 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 20,000 | 235,800 | 149,000 | |
| Feb 05 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 36.41 | 20,000 | 728,200 | 6,826 | 26.8 K to 6.8 K (-74.55 %) |
| Feb 05 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 20,000 | 235,800 | 26,826 | 6.8 K to 26.8 K (+293.00 %) |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 5,000 | 58,950 | 169,000 | |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 10,000 | 117,900 | 174,000 | |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 35.64 | 5,000 | 178,198 | 6,826 | 11.8 K to 6.8 K (-42.28 %) |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 5,000 | 58,950 | 11,826 | 6.8 K to 11.8 K (+73.25 %) |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 35.01 | 10,000 | 350,083 | 6,826 | 16.8 K to 6.8 K (-59.43 %) |
| Jan 23 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 10,000 | 117,900 | 16,826 | 6.8 K to 16.8 K (+146.50 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 10,000 | 117,900 | 184,000 | |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 10,000 | 117,900 | 194,000 | |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 30.00 | 10,000 | 300,000 | 6,826 | 16.8 K to 6.8 K (-59.43 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 10,000 | 117,900 | 16,826 | 6.8 K to 16.8 K (+146.50 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 25.18 | 10,000 | 251,838 | 6,826 | 16.8 K to 6.8 K (-59.43 %) |
| Jan 15 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 10,000 | 117,900 | 16,826 | 6.8 K to 16.8 K (+146.50 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | A | 21.38 | 27,000 | 577,260 | 27,000 | |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Grant | A | 0.00 | 5,700 | 0 | 6,826 | 1.1 K to 6.8 K (+506.22 %) |
| Jan 16 2013 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | A | 11.79 | 204,000 | 2,405,160 | 204,000 |
Page: 1